You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 27, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Alison R Moliterno1, Hannah Kaizer1
1Johns Hopkins University School of Medicine, Baltimore, MD.
Genomic assessment, particularly the JAK2V617F mutation, is crucial for diagnosing and managing myeloproliferative neoplasms (MPNs). Understanding genetic profiles improves risk stratification, treatment selection, and outcomes for MPN patients.
Area of Science:
Background:
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018